Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate.
Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths.
David Dillon will retire as chairman of the board on Dec. 31 after 38 years of service.
Johnson & Johnson Family of Consumer Companies has named Jorge Mesquita as worldwide chairman, effective Dec. 15, overseeing such brands as Aveeno, Johnson’s, Listerine, Neutrogena and Tylenol.
Quaker Oats Co., a unit of PepsiCo, on Thursday announced a line of new breakfast products. The brand said it hopes the new additions will give consumers an exciting, nutritional option for the cold months ahead.
Kroger on Thursday announced that Nora Aufreiter has been elected to the company's board of directors.
The Little Clinic and UC Health have announced that they are expanding on their relationship to include diabetes management, beginning in December, inside seven pilot program locations.
Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg.
Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths.
Beiersdorf’s Nivea Men brand will launch new products in January for guys with sensitive skin.